Menu
Search
Home > Courses > Prevention of Anal Cancer in HIV-Positive Men and Women: An Evolving Landscape

Prevention of Anal Cancer in HIV-Positive Men and Women: An Evolving Landscape

Prevention of Anal Cancer in HIV-Positive Men and Women: An Evolving Landscape
Play
Sorry, this learning module is not available for mobile devices.
Original Release Date: 9/11/2018
Termination Date: 09/10/2021
Review Date: 12/7/2018
Presenter
  • Joel Palefsky, MD, CM, FRCP(C)
    Professor of Medicine
    University of California San Francisco School of Medicine
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Understand how the epidemiology of anal cancer, pre-cancer and HPV infection in HIV-positive individuals is changing.
  2. Know current methods for the prevention of anal cancer in HIV-positive individuals.
  3. Be aware of the rationale for, and current status of, the Anal Cancer/HSIL Outcomes Research (ANCHOR) study.
Presenter Bio
Joel Palefsky, MD, CM, FRCP(C)
Joel Palefsky, MD, FRCP(C) is Professor of Medicine at the University of California San Francisco. A native of Montreal,  Dr. Palefsky graduated from the McGill University School of Medicine.  He trained in internal medicine at McGill University and infectious diseases at Stanford University.  He founded and directs the world's first clinic devoted to prevention of anal cancer, the UCSF Anal Neoplasia Clinic Research and Education Center.   He is the founding president of the International Anal Neoplasia Society and immediate past president of the International Papillomavirus Society.  He has published extensively on natural history and molecular pathogenesis of HPV infection particularly in the setting of HIV infection and his laboratory is currently focused on development of targeted molecular approaches to treatment of HPV-associated disease.  He is the protocol chair of the ANCHOR study and is the author of over 350 publications.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit on September 11, 2018 and will terminate September 10, 2021.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

 Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. Joel M. Palefsky (Presenter) has had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Research support from Antiva, and Merck; Consultant to Agenovir, Novan, Vaccitech, and Virion; Stock options on Agenovir, and Ubiome; Speaker for Janssen. Dr. Palefsky submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Gilead Sciences, Janssen Therapeutics (a division of Janssen Products, LP), Merck & Co., and ViiV Healthcare.

Details: 

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules